Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 6.09%

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has an Asset Resilience Ratio of 6.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Aohua Photoelectricity Endoscop working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥113.00 Million
≈ $16.54 Million USD Cash + Short-term Investments

Total Assets

CN¥1.86 Billion
≈ $271.68 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shanghai Aohua Photoelectricity Endoscop assets under control.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Shanghai Aohua Photoelectricity Endoscop for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥113.00 Million 6.09%
Total Liquid Assets CN¥113.00 Million 6.09%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A maintains only 6.09% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic plc
SA:MDTC34
Medical Devices 7.82%
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Medartis Holding AG
SW:MED
Medical Devices 0.00%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Mediantechn
PA:ALMDT
Medical Devices 0.45%

Annual Asset Resilience Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 7.25% CN¥126.81 Million
≈ $18.56 Million
CN¥1.75 Billion
≈ $255.89 Million
-13.66pp
2023-12-31 20.91% CN¥333.60 Million
≈ $48.82 Million
CN¥1.60 Billion
≈ $233.41 Million
-9.45pp
2022-12-31 30.37% CN¥443.40 Million
≈ $64.88 Million
CN¥1.46 Billion
≈ $213.66 Million
+26.96pp
2021-12-31 3.41% CN¥46.03 Million
≈ $6.74 Million
CN¥1.35 Billion
≈ $197.44 Million
--
pp = percentage points

About Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A

SHG:688212 China Medical Devices
Market Cap
$543.88 Million
CN¥3.72 Billion CNY
Market Cap Rank
#11910 Global
#3428 in China
Share Price
CN¥27.60
Change (1 day)
-0.97%
52-Week Range
CN¥25.37 - CN¥51.78
All Time High
CN¥81.71
About

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more